Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Biozein is a Brazilian biotechnology company specializing in the development of innovative drug delivery systems and biomaterials using zein, a natural protein derived from corn. The company's proprietary platform focuses on the microencapsulation of active pharmaceutical ingredients (APIs), nutraceuticals, and cosmetic compounds to enhance stability, solubility, and controlled release. By leveraging the unique hydrophobic and biocompatible properties of zein, Biozein provides sustainable alternatives to synthetic polymers for various health and wellness applications. The company primarily operates as a research and development entity, collaborating with industrial partners to integrate its encapsulation technology into final commercial products.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on BioZein.